Like every year, the List of prohibited substances and methods issued by the World Anti-Doping Agency (WADA) came into effect on 1er January 2023. The 2023 List was approved by the WADA Executive Committee at its meeting on September 23, 2022 then originally published on September 29, 2022.
The List is one of eight International Standards that all signatories du World Anti-Doping Code (the Code) must respect. It indicates which substances and methods are prohibited outside comptitle and in competition and which substances are prohibited in certain sports.
Main changes
All major changes for 2023 are described in the Summary of the main changes and explanatory notes 2023, also published le September 29, 2022, at the same time as the 2023 Monitoring Program. The CMA presents the main developments in this article.
Therapeutic use authorization program (TUE)
Athletes who have a legitimate medical reason for using a Prohibited Substance or Prohibited Method on the List may request a therapeutic use exemption (AUT) to determine if they meet the criteria set out in the International Standard for Authorization of Therapeutic Use (SIAUT). The TUE program is a rigorous and necessary part of elite sport that is widely accepted by athletes, physicians and stakeholders in the anti-doping community.
Learning resources
In addition to the materials linked above, WADA has provided, or will provide, a number of educational resources as part of its Support program for signatories for the implementation of the Code (CISP), which can be consulted on the Agency Anti-Doping Education and Learning Platform (ADEL). These resources include:
- CISP Checklist – Implementing the Revised List
- Tramadol Fact Sheet for Athlete and Athlete Support Personnel
- Tramadol Fact Sheet for Healthcare Professionals
- Guide for athletes and their support staff for the 2023 List
WADA will seek to develop other educational activities, such as webinars, to support ADOs in their efforts to educate their target audiences about the change regarding tramadol.
